Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis. [electronic resource]
- BMC neurology May 2006
- 18 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2377
10.1186/1471-2377-6-18 doi
Computer Systems Genes--drug effects Genes, Immediate-Early Humans Interferon Type I--adverse effects Interferon-beta--pharmacology Ligands Lymphocytes--metabolism Male Middle Aged Monocytes--metabolism Multiple Sclerosis--drug therapy Oligonucleotide Array Sequence Analysis Receptors, CCR2 Receptors, CXCR3 Receptors, Chemokine--blood Recombinant Proteins Reverse Transcriptase Polymerase Chain Reaction Time Factors